AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform May 19, 2026
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease May 19, 2026
Amii Fuels Canada’s AI Momentum as Upper Bound Opens with 53% Growth and 11,000 Global Attendees. May 19, 2026
GNS DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Genius Group Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Against Citadel Securities LLC and Virtu Americas LLC – GNS August 17, 2026
